Table 1 Baseline characteristics of the population, such as demographic features and analyzed parameters
Parameters | Total subjects (n = 409) |
|---|---|
Age (years) | 56.4 ± 17.4 |
Sex [n (%)] | |
- Male - Female | 40 (9.8%) 369 (90.2%) |
BMI (kg/m²) | 28.2 ± 5.7 |
Dyslipidemia [n (%)] | 253 (63.7%) |
Diabetes [n (%)] | 119 (29.5%) |
Levothyroxine [n (%)] | 266 (81.6%) |
Hypothyroidism [n (%)] - Subclinical - Clinical | 26 (6.4%) 25 (6.1%) 1 (0.25) |
Hyperthyroidism [n (%)] - Subclinical - Clinical | 37 (9.0%) 28 (6.8%) 9 (2.2%) |
TSH (µUI/mL) | 2.3 ± 3.3 |
FT4 (ng/dL) | 1.1 ± 0.6 |
FT3 (pg/mL) | 2.7 ± 0.5 |
TPOab (UI/mL) | 36.8 [1.2, 222.2] |
Tgab (UI/mL) | 12.5 [2.7, 55.6] |
TC (mg/dL) | 186.0 ± 38.8 |
LDL (mg/dL) | 106.5 ± 32.7 |
HDL (mg/dL) | 57.6 ± 18.3 |
Triglycerides (mg/dL) | 98.0 [73.0, 135.0] |
Hemoglobin A1c (%) | 5.8 ± 0.8 |
Fasting glucose (mg/dL) | 96.8 ± 30.2 |
CRP (mg/L) | 4.4 ± 12.9 |
Folic acid | 7.5 ± 4.3 |
Dimensions [n (%)] | |
- Decreased - Normal | 90 (24.3%) 231 (62.4%) |
- Increased | 49 (13.2%) |
Nodular pattern [n (%)] | |
- Any - Uninodular - Multinodular | 184 (49.1%) 72 (19.2%) 119 (31.7%) |
Thyroid volume (mL) | 10.3 ± 9.2 |